New Drug Toripalimab Improves Survival in Nasopharyngeal Cancer New Drug Toripalimab Improves Survival in Nasopharyngeal Cancer

Improved survival in a phase 3 trial where the new drug was added onto chemotherapy could move immunotherapy to the first line, say experts.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news